Cota raises $18M  funding


What does Cota do?

Cota, is a cancer outcomes and data tracking company based in New York which uses patented digital classification system for assessing patient results on special treatment protocols. The company’s customers include healthcare providers, pharma companies and insurance companies. It partners with many major pharmaceutical companies in North America including Celgene and Novartis, and with Foundation Medicine which is a data provider.

How much Cota was funded?

The company raised $3.7M on September 23, 2014 from Horizon Healthcare Services and Med-Metrix.

What is next for Cota?

The company’s partner, A. Dana Callow, Jr. will join the company’s board of directors. The company is commited to being a part of the larger solution for its country wide complex healtcare confusions and the company is a part of the solution. The company has made huge progress on an exciting mission. It has seen a strong growth in revenue and the rapid adoption of the products across many markets. It has great capacity to make a significant impact on the cost of quality healthcare and on how patients can be matched to the changing protocols and best of care. The company aims at being a part of larger solution to the dilemmas in healthcare.

More about Cota

Cota was founded on June 7, 2006. It has its headquarters in Murcia, Murcia. It is a telecommunications operator scope which helps people in exploiting public electronic communications networks by using public radio and services other operators that need it. The company builds research grade, real world data for greatly improving outcomes, reducing cost and ensuring the right care for the right patient each time. It began as a provider of service and broadcasting analog TV signals of the Public Broadcating Corporation, and  the distribution and transport of digital multi channel DTT Autonomy.